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INTRODUCTION
Development of brain during developing period can be
influenced by many factors, such as genetic characteristics,
infection, exposure to drugs, environmental pollutants,
trauma, physical stress, or unknown factors. Fetal death
can occur when the brain is seriously damaged. Congenital
malformation, growth retardation or abnormal functional
development can also occur, depending on the severity of
brain damage.
Developmental disability shows life-long alteration of
behavior with no obvious physical malformation. Cerebral
palsy, mental retardation, attention-deficit hyperactivity
disorder, autism, and learning disability are included in
this category of disorder.Manyneurological and psychiatric
symptoms accompany the developmental disability, and
various symptoms are elicited from various damaged areas
of brain, although the same etiological factor is related to
the disorder (Grether et al, 1992;Rumeau-Rouguette et al,
1992; Roland &Hill, 1997). It is practically impossible to
prevent the cause of developmental disability even if the
cause is known.On the other hand,whatever the causemay
be, altered behavior is elicited from altered function of
brain. Therefore, understanding of pathophysiology is im-
portant to ameliorate symptomswhich have occurred alrea-
dy.However, there is presently no interventionmethod tar-
geting brain and even an accepted animal model for develo-
pmental disability. The animal model has been developed
by applying environmental risk factors. Nevertheless, the
failure of development of an animal model for develop-
mental disability suggests that there may be another
factor(s) in addition to the environmental risk factors. In
the present study, we developed an animal model for
developmental disability, based on the deranged 5-hydroxy-
tryptamine (5-HT) system in addition to infection during
development,an important environmental factor. Induction
of inflammation was to generate periventricular leukoma-
lacia, a typical pathological finding of cerebral palsy (Lin,
2003; Himmelmann et al, 2005), and the derangement of
5-HT system was to suppress active plasticity of developing
brain.
In the present study, we applied two factors to develop
an animal model for developmental disability. Lipopoly-
saccharide (LPS), a Gram-negative bacterial toxin,was ad-
ministered to the lateral ventricle for generating inf-
lammatory response in brain, and NAN-190, a 5-HT1A
receptor antagonist was also administered simultaneously
because we found protection effect of 5-HT1A receptor
agonist on brain function (Lee et al, 2002).
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METHODS
Animals
To minimize and standardize unwanted environmental
stimulation from in utero life, Sprague-Dawley rats were
bred and the offsprings were reared in a controlledmanner.
The animals were supplied from the Division of Laboratory
Animal Medicine, Yonsei University College of Medicine.
Animals were cared in a SPFbarrier area,and temperature
(22±1oC) and humidity (55%) were constantly controlled
with a 12：12 hour light:dark cycle (lights on 07:00 hour).
Food (PMI Feeds, Inc, IN,USA)and tap water (membrane
filtered purified water) were available ad libitum. Nulli-
parous female and proven breeder Sprague-Dawley male
rats were used for breeding. Twelve hours after confirming
delivery, pups were divided by gender and weighed. We
used litters which included five males and five females or
more, and pups were culled five males and five females in
a litter. All animal experiments were approved by the
Committee for Care and Use of Laboratory Animals at
Yonsei University. The Guidelines and Regulations for the
Use and Care of Animals in Yonsei University was
consistent with the NIH guideline Guide for the Care and
Use of Laboratory Animals, 1996 revised (NIH, 1996).
Drug treatment and grouping
On postnatal day (PND)5,NAN-190HBr (Sigma-Aldrich
Chemical Co., Yongin-city, Korea), dissolved in polyethy-
leneglycol 400 (vehicle),was administered intraperitoneally
(i.p.)at a dose of 10mg/kg/2ml.Thirtymin after NAN-190,
LPS (Sigma-Aldrich Chemical Co., Yongin-city, Korea) dis-
solved in physiological saline (1% LPS, 10 mg/ml), was
administered intracerebroventricularly (i.c.v.) at a dose of
20μg/2μl (Lu et al, 1995).The location of i.c.v.was 1.0mm
right lateral and 1.0 mm posterior to the bregma, and the
tip of the needle of the Hamilton syringe was situated 2
mm below the scalp. The rat was moved to the cage with
heating blanket, and it was then moved to the cage of
mother after recovering body temperature.
We had 4 experimental groups:1) Vehicle+ Saline (Con-
trol): physiological saline 2μl i.c.v. 30 min after vehicle 2
ml/kg i.p., 2) Vehicle+ LPS: LPS 2μl i.c.v. 30 min after
vehicle 2 ml/kg i.p., 3) NAN+ Saline: physiological saline
2 μl i.c.v. 30 min after NAN-190 10 mg/kg/2 ml i.p., and
4) NAN+ LPS: LPS 2μl i.c.v. 30 min after NAN-190 10
mg/kg/2 ml i.p.. All experimental animals were males, and
each group contained at least 12 animals, and more than
6 animals were assigned to each group for the later
individual experiment.
Behavioral measurements
Righting reflex, Placing reaction, Toe spreading test:
Neuronal reflexes for developmental indices were per-
formed PND 8 and 21. They were measured by slightly
modified methods of Huston and Bures (1976). For the
righting reflex, a rat was held in the lumbosacral region.
When the body was tilted to the left and right, the head
moved in the opposite direction in order to maintain the
original position in the normal reflex. For the placing
reaction, a rat was restrained at the edge of the table and
one hindleg was displaced, so that it hung over the edge.
The leg was withdrawn immediately to the table surface
in the normal reflex. For the toe spreading test, a rat was
placed on a plexiglass sheet suspended over amirror,which
made it possible to observe the position of the toes of the
rat. When the plexiglass platform was suddenly tilted or
moved up and down, the toes were extended and spread
in the normal reflex.
Rotarod test:Rotarod test was performed onPND21.For
the rotarod test, a rat was placed on the rotating rod (7.5
cm diameter), and its falling down latency was measured
as an index of motor coordination. The rotating speed was
gradually increased from 0 (at 0 sec) to 40 rpm (at 300 sec).
A session consisted of 3 trials with an interval of 5 min.
Wire maneuver test:Wire maneuver test was performed
on PND 28. For the wire maneuver test, a rat was hung
by both forelimbs on the wire 50 cm high from the floor.
The diameter of the wire was 1 mm. The body of a rat was
maintained parallel to the floor by hanging the tail by
experimenter's hand, and the tail was then released. Its
falling down latency was measured as an index of forelimb
strength.
Tilt-table test:Tilt-table test was performed on PND 98.
For the tilt-table test, a rat was placed on a platform
positioned parallel to the floor. The platform (73.5 cm×47
cm)was made of rubber floor on the plexiglass not to slip.
The platform was suddenly tilted by 30o, letting the head
located downwards. It turned to face up the slop in the
normal reflex. The latency to turn the body parallel to the
floor was measured as an index of equilibrium ability.
Morris water maze test:For measuring spatial learning
ability, Morris water maze test was performed. This test
started on PND 196. A rat was allowed to find hidden
platform in the circular water tank (diameter:2 m), which
was filled with black ink-mixed opaque water. A rat was
required to find an invisible escape platform just beneath
the surface of the water by using surrounding cues. A trial
consisted of 60 sec, and an experimenter guided the rat to
the platform if it could not find the platform. One daily
session consisted of 4 trials, and the rat was released in
4 different quadrants in each trial. On the 7th day of trai-
ning, the probe test was done, in which the platform was
removed and the time spent in platform-quadrant was
measured as an index of spatial memory. From the 8th day,
four day session was added to the original training for the
reversal training, in which the platform was moved to the
opposite quadrant to the original location. Formation of
new strategy could be measured in the reversal training.
After finishing the training, a cue test was done to confirm
that the rat's visual ability was normal. For the cue test,
a rat was allowed to find the platform which had a visible
flag on it.
Immunohistochemistry for myelin basic protein (MBP)
and 5-HT
A set of rats were sacrificed on PND 130 for immuno-
histochemical study. Rats were overdosed with pentobar-
bital and transcardially perfused first with heparinized iso-
tonic saline containing 0.5% NaNO2, followed by ice-cold
4% paraformaldehyde in 0.1 M sodium phosphate buffer.
The brains were dissected out immediately, blocked, post-
fixed for 2 hours, and transferred to 30% sucrose for cryo-
protection. Forty micron coronal sections were cut on a
freezing, sliding microtome (HM440E, Microm Co., Wall-
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dorf, Germany). Free-floating tissue sections were treated
for 30 min with 0.2% Triton X-100 (1% BSA: 0.2% Triton
X-100: 0.1 M PBS). Then, the tissues were incubated for
16 hours with monoclonal anti-MBP antibody (Oncogene,
Cambridge,USA)or polyclonal anti-5-HT antibody (Eugene
Tech, USA). After washing twice in PBS-BSA (0.1 M PBS:
0.5% BSA), incubated for 1 hour with biotinylated anti-
rabbit IgG (1：200dilution,Vector Laboratories,CA,USA),
and then bound secondary antibodies were amplified with
theABCkit (Vectastatin Elite Kit,Vector Laboratories,CA,
USA). Antibody complexes were visualized with 0.05%dia-
minobenzidine for 5 min. Sections were mounted in anato-
mical order onto gelatin-coated slides from 0.05 M PB, air
dried, dehydrated through a graded ethanol to xylene, and
coverslipped.The slides were observed by using lightmicro-
scope and MCID imaging system.
Data analysis
Data are expressed as means±S.E., and statistical ana-
lyses were completed with an aid of StatView program
(version 5.01, The SAS Instiute, CA, USA). All data were
analyzed by one-way analysis of variance (ANOVA), and
preplanned comparisons were performed by Fisher's pro-
tected least significance difference (PLSD) test.
RESULTS
Effects of neonatal LPS and/or NAN-190 on body
weight
The difference of body weight was first observed on PND
49,and the pattern wasmaintained thereafter.The Vehicle
+ LPS group showed lower body weight than that of the
Vehicle+ Saline group and the Vehicle+ NAN group (Fig.
1). On the other hand, an increase of body weight during
24 hours after treatment with drugs on PND 5 was noted
in the Vehicle+ Saline group and the NAN+ Saline group,
and a decrease was noted in the Vehicle+ LPS group and
the NAN+ LPS group (Fig. 2). However, body weights of
all 4 groups of animals increased during the next 24 hours,
suggesting normal feeding and development.
Effects of neonatal LPS and/or NAN-190 on beha-
vioral development
In the placing reaction test, the NAN+ LPS group,
comparedwith theVehicle+ Saline group,showed impaired
reflex on PND21,although this differencewasnot observed
on PND 8. All pups showed intact reflex for the placing
reaction. No abnormality was noted in the righting reflex
(Fig. 3). Impaired motor coordination was noted in the
Vehicle+ LPS group on PND 21 by the rotarod test (Fig.
4). Impaired forelimb muscle strength was also noted in
the NAN+ LPS and the Vehicle+ LPS groups on PND 28
by the wire maneuver test (Fig. 5). The NAN+ LPS group
also showed impaired equilibrium ability on PND 98 by the
tilt-table test (Fig. 6). On PND196,Morris water maze test
was started. After 6 days'training for spatial memory, the
probe test on the 7th day and the reversal training for 4
days were performed. No significant differences between
groups were found in this memory test (Fig. 7).
Effects of neonatal LPS and/or NAN-190 on the
immunoreactivity of myelin basic protein
Animals were sacrificed on PND 130 for immunohisto-
chemical studies.The lateral ventricles werewidened in the
LPS-treated groups, suggesting tissue damage by LPS.The
defect of white matter was also observed in the groups
treated with LPS neonatally (Fig. 8). When the width of
white matter in the periventricular region was measured,
the width of the Vehicle+ LPS and the NAN+ LPS groups
were decreased more than that of other groups (Fig. 8).
Effects of neonatal LPS and/or NAN-190 on the
immunoreactivity of 5-HT
The 5-HT immunoreactivity in the thalamus region was
measured by the density of the serotonergic fibers after
dark field examination. The relative optical density was
measured by the MCID system. The immunoreactivity of
the serotonergic fibers was higher in the Vehicle+ LPS and
NAN+ LPS groups than that of the Vehicle+ Saline and the
NAN+ Saline groups (Fig. 9). Similar pattern was observed
also in the cerebral cortex (Fig. 10).
Fig. 1. Body weights after injection with lipopolysaccharide and/or
NAN-190 on PND 5. In the Vehicle+ LPS group, *p＜0.05, **p＜
0.01 compared with the Vehicle+ Saline group. + p＜0.05, + + p＜
0.01, compared with the NAN+ Saline group, #p＜0.05, compared
with the NAN+ LPS group.
Fig. 2. Body weight gain 24 hours after injection with lipo-
polysaccharide and/or NAN-190 on PND 5. *** p＜0.001, compared
with the Vehicle+ Saline group.
116 JG Kim, et al
DISCUSSION
The present study showed that various long-term
behavioral alterations can be made by neonatal manipu-
lation of two factors rather than one factor, and these
altered behaviors can be one of the symptoms of develo-
pmental disability.
In this study, we tried to establish an animal model for
developmental disability on the basis of brain infection
Fig. 3. Placing reaction measured on PND 8 and 21 after injection
with lipopolysaccharide and/or NAN-190 on PND 5. *p＜0.05,
compared with the Vehicle+ Saline group.
Fig. 7. Morris water maze test (1) started on PND 196 and the probe test (2) after injection with lipopolysaccharide and/or NAN-190
on PND 5.
Fig. 4. Rota-rod test on PND 21 after injection with lipopoly-
saccharide and/or NAN-190 on PND 5. *p＜0.05, compared with
the Vehicle+ Saline group.
Fig. 5. Wire maneuver test on PND 28 after injection with
lipopolysaccharide and/or NAN-190 on PND 5. *p＜0.05, compared
with the Vehicle+Saline group.
Fig. 6. Tilt-table test on PND 98 after injection with lipopoly-
saccharide and/or NAN-190 on PND 5. *p＜0.05, compared with
the Vehicle+Saline group, + p＜0.05, compared with the Vehicle+
LPS group.
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Fig. 8. (1)Myelin basic protein (MBP) immunohistochemistry on PND 130 after injection with lipopolysaccharide and/or NAN-190 on PND
5. Left 2 panels: whole brain. Right 4 panels: periventricular region (×400). (2) Distance of white matter in the periventricular region
on PND 130 after injection with lipopolysaccharide and/or NAN-190 on PND 5. ***p＜0.001 vs. the Vehicle+ Saline group, ##p＜0.01, ###p＜
0.001 vs. the NAN+ Saline group. n=3.
Fig. 10. 5-HT immunoreactive fiber (1) and measured density (2) of 5-HT immunoreactive fiber in the frontal cortex on PND 130 after
injection with lipopolysaccharide and/or NAN-190 on PND 5. **p＜0.01, ***p＜0.001 compared with the Vehicle+ Saline group. #p＜0.05,
##p＜0.01 compared with the NAN+ Saline group.
Fig. 9. 5-HT immunoreactive fiber (1) and measured density (2) of 5-HT immunoreactive fiber in the thalamus on PND 130 after injection
with lipopolysaccharide and/or NAN-190 on PND 5. *p＜0.05 compared with the Vehicle+ Saline group.
118 JG Kim, et al
together with altered 5-HT system. Periventricular leuko-
malacia (PVL) was elicited by LPS-induced inflammatory
reaction, and altered 5-HT system was elicited by injecting
5-HT1A receptor antagonist, NAN-190. PVL is a pheno-
menon of disappearance of periventricular white matter (Yi
et al, 2000; Olaf et al, 2001). PVL is a representative
pathologic finding of developmental disability, especially in
the diplegic type of cerebral palsy (Elie & Marret, 2001).
In this type of cerebral palsy, 90% of patients show PVL
(Krageloh-Mann et al, 1995), and children with PVL suffer
from 60∼100% cerebral palsy (Leviton & Panetth, 1990).
PVL can be elicited experimentally by hypoxia-ischemia
(Rice et al, 1981; Hisakazu et al, 1999), excitotoxicity
(Marret & Muckendi, 1995), thyroid deficiency (Anderson
et al, 1987; Gressens et al, 1998), and inflammatory
reaction (Gilles et al, 1977; Yoon et al, 1997;Zhengwei et
al, 2000).Many of these methods, however, are not specific
for PVL because hypoxia-ischemia can damage gray matter
as well as white matter, and hormone deficiency can affect
various function of the body. Various cytokines play a role
in the inflammatory reaction induced by LPS. Tumor
necrosis factor-alpha (TNF-α), interleukin-1beta (IL-1β),
interleukin-6 (IL-6) and nitric oxide (NO) are generated,
and these cytokines destroy immature or developing
oligodendrocytes, resulting in damages in the white matter
(Jhodie, 2002; Pang et al, 2003).
5-HT is an important neurotransmitter in the brain, and
it exists in the raphe nucleus with a high concentration.
When 5-HT activity increases, food intake and aggressive-
ness decrease.On the other hand, obesity and aggressiven-
ess can occur when 5-HT activity decreases.Following poin-
ts may explain that 5-HT plays a key role in conduction
of brain function. 1) 5-HT is a phylogenetically very old
compound and found in insects or plants.This facts suggest
that there is a possibility that 5-HT plays a key role in
adapting to varing environment, which is a basic function
of the life (Berendsen &Broekkamp, 1990). 2) 5-HT exists
ubiquitously in the brain and shows seldom varicosities
(Descarries et al, 1990). This distribution characteristic
suggests that 5-HT plays a role in regulating, rather than
specifically acting, brain function, and promotes a harmony
of the whole brain function. 3) 5-HT shows lower activity
than other neurotransmitters, such as norepinephrine or
dopamine, in the normal physiological condition (Sanders-
Busch, 1990). This characteristic enables it to act promptly
under the situation of adapting to varing environment,
although it may not have an important role in the resting
condition. 4) Changed activities of serotonergic neurons
result in metabolism and blood flow of the brain (Cohen
et al, 1996).This is an evidence of direct regulation of brain
function by 5-HT. 5) 5-HT plays a role as a neurotran-
smitter as well as a neurotrophic factor (Lauder, 1990,
1995). 5-HT is intimately related with S-100β which is
released from astrocytes. S-100β is synthesized and
released by the activation of 5-HT1A receptors in the
astrocyte, and S-100βplays a role of a neurotrophic factor
for the serotonergic neuron (Lauder & Liu, 1994; Whita-
ker-Azmitia & Azmitia, 1994). S-100β is an important
factor for synaptic formation. The synaptic formation is
decreased, and learning ability is impaired after elimina-
ting 5-HT on PND 2 (Mazer et al, 1997). All the above
characteristics of 5-HT indicate that it plays an important
role in the neuronal plasticity to adapt to changing envi-
ronment.
The present study showed that two-factor manipulation
was better than single factor in terms of generation of
variable symptoms in an animal model for developmental
disability. Decrease of body weight gain and impaired
motor coordination were observed in the Vehivle+ LPS
group. In both the Vehicle+ LPS and the NAN+ LPS
groups, no weight gain was noted during 24 hours after
injection, and impaired forelimb muscle strength was
observed.These groups also showeddecreasedwhitematter
distance and increased serotonergic fibers in the thalamus
and cortical areas. Impaired placing reaction and equili-
brium ability were observed only in the NAN-LPS group.
Developmental disabilities in human are usually dia-
gnosed after 2 years of age as cerebral palsy, mental
retardation or learning disability, etc. Late appearance of
definite human symptoms of developmental disabilities was
also shown in the animal in the present study, in which
a decreased body weight gain occurred after 49 days of age,
and an impaired placing reaction occurred on PND 21, but
not on PND 8.
A decrease in the amount of white matter was observed
in the Vehicle+ LPS group as well as in the NAN+ LPS
group.This finding suggests that 5-HT is not related to the
content of white matter, as expected. An increase of
serotonergic fibers was observed in theVehicle+ LPS group
as well as NAN+ LPS group. It is consistent with earlier
report which showed that 5-HT release in the hippocampus,
thalamus,and hypothalamus was increased by LPS (Nolan
et al, 2000). This reaction to the inflammation could be a
compensatory mechanism of the brain, and the increased
5-HT release may play a role in neuronal plasticity of the
damaged brain.In the present study,NAN-190antagonized
5-HT1A receptors activated by the function of increased
serotonergic fibers, therefore, the NAN-190+ LPS group
showed more impaired neuronal reflex in the placing reac-
tion test and more impaired equilibrium ability in the tilt
table test than the Vehicle+ LPS group.
In summary, we tried to establish an animal model for
developmental disability by adding a derangement of 5-HT
system to an important etiologic factor, inflammation. This
two-factor animal model could generate several behavioral
expressions similar to human developmental disabilities.
Combination of important etiologic factors and possible
underlying defects could provide a promising strategy of
establishing an animal model for developmental disability,
although two factor animal model of the present study is
not perfect.
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